Skip to content

Clinical trials

Phase 4 Lung Diseases, Interstitial trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 4 Status: Unknown status Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20161
20191
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Qilu Hospital of Shandong University2
First Affiliated Hospital Xi'an Jiaotong University1
RenJi Hospital1
Royal Brompton & Harefield NHS Foundation Trust1
The First Affiliated Hospital with Nanjing Medical University1
University of Zurich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial7
Myositis3
Arthritis, Rheumatoid2
Connective Tissue Diseases2
Dermatomyositis2
Hypertension, Pulmonary2
Scleroderma, Systemic2
Idiopathic Pulmonary Fibrosis1
Pulmonary Fibrosis1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.